Asmanex Twisthaler

Dermatophytosis, Asthma, Itching + 14 more

Treatment

2 FDA approvals

20 Active Studies for Asmanex Twisthaler

What is Asmanex Twisthaler

Mometasone furoate

The Generic name of this drug

Treatment Summary

Mometasone furoate is a steroid-based drug used to treat asthma, allergies, and certain skin conditions. It is much more potent than other corticosteroids, and is available as a dry powder inhaler, nasal spray, or ointment.

Elocon

is the brand name

image of different drug pills on a surface

Asmanex Twisthaler Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Elocon

Mometasone furoate

1987

114

Approved as Treatment by the FDA

Mometasone furoate, also known as Elocon, is approved by the FDA for 2 uses including Asthma and Asthma .

Asthma

Helps manage Asthma

Asthma

Helps manage Asthma

Effectiveness

How Asmanex Twisthaler Affects Patients

Mometasone is a type of synthetic steroid. It has a stronger effect on the body's glucocorticoid receptors than other similar drugs, and it is more selective in its action on the body's mineralocorticoid receptors. Once it is taken, mometasone furoate moves through the cells and activates pathways that decrease inflammation.

How Asmanex Twisthaler works in the body

Mometasone helps to reduce asthma symptoms by limiting the activity of mast cells, eosinophils, basophils, and lymphocytes. It also works to reduce the effects of histamine, leukotrienes, and cytokines. This is done by the drug binding to a glucocorticoid receptor in the cell. This binding causes the receptor to move to the nucleus of the cell, where it then dimerizes and binds to a DNA sequence called the glucocorticoid response element. The glucocorticoid response element helps to reduce inflammation by blocking certain transcription factors.

When to interrupt dosage

The measure of Asmanex Twisthaler is contingent upon the perceived ailment, including Dermatitis, Eczematous caused by superficial Fungal skin contamination, Psoriasis and Skin Diseases, Eczematous. The measure of dosage varies, as per the technique of administration (e.g. Powder or Topical) specified in the following table.

Condition

Dosage

Administration

Dermatophytosis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Asthma

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Itching

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Atopic Dermatitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

prophylaxis of seasonal Allergic rhinitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Hay Fever

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Seasonal Allergies

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Skin Diseases, Eczematous

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Communicable Diseases

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Systemic Treatment

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Nasal Decongestants

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Communicable Diseases

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Bacterial Infections

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Dermatitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Nasal, Spray, metered - Nasal, Spray, metered, Inhalant, Inhalant - Respiratory (inhalation), Respiratory (inhalation), Cream, Cream - Topical, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Implant, Implant - Intrasinal, Intrasinal, Kit, Kit - Topical, Spray, Capsule, Capsule - Respiratory (inhalation), Powder, Powder - Respiratory (inhalation), Solution - Topical, Solution, Spray - Nasal

Warnings

Asmanex Twisthaler Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Status Asthmaticus

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Mometasone Furoate may interact with Pulse Frequency

There are 20 known major drug interactions with Asmanex Twisthaler.

Common Asmanex Twisthaler Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Mometasone furoate.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be increased when combined with Mometasone furoate.

Aldesleukin

Major

The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone furoate.

Alectinib

Major

The metabolism of Alectinib can be increased when combined with Mometasone furoate.

Almotriptan

Major

The metabolism of Almotriptan can be decreased when combined with Mometasone furoate.

Asmanex Twisthaler Toxicity & Overdose Risk

Taking too much of a mometasone furoate inhaler can cause excessive amounts of cortisol and adrenal gland suppression. Animal studies have shown that taking a high enough dose of the drug may cause fetal harm, so pregnant patients should carefully weigh the risks and benefits. The drug may be present in breast milk, so caution should be used when administering to nursing mothers. Kids may experience slower growth and should take the lowest effective dose for the inhaler. Elderly patients may be more sensitive to the drug, and those with moderate to severe liver problems should be cautious when taking the medication. It's unknown how the drug affects renal impairment

image of a doctor in a lab doing drug, clinical research

Asmanex Twisthaler Novel Uses: Which Conditions Have a Clinical Trial Featuring Asmanex Twisthaler?

279 active studies are examining the ability of Asmanex Twisthaler to provide relief from Atopic Dermatitis, Seasonal Allergies and Psoriasis.

Condition

Clinical Trials

Trial Phases

Asthma

87 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Dermatophytosis

0 Actively Recruiting

Systemic Treatment

0 Actively Recruiting

Seasonal Allergies

0 Actively Recruiting

Itching

4 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1

Hay Fever

0 Actively Recruiting

Skin Diseases, Eczematous

0 Actively Recruiting

Bacterial Infections

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

prophylaxis of seasonal Allergic rhinitis

0 Actively Recruiting

Dermatitis

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Nasal Decongestants

8 Actively Recruiting

Early Phase 1, Phase 4, Not Applicable, Phase 3, Phase 2

Atopic Dermatitis

16 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Phase 4, Phase 1

Communicable Diseases

0 Actively Recruiting

Asmanex Twisthaler Reviews: What are patients saying about Asmanex Twisthaler?

5

Patient Review

4/26/2014

Asmanex Twisthaler for Asthma

Overall, this treatment was effective in reducing my asthma symptoms and I didn't have to use my emergency inhaler as much. However, there were some side effects that came along with it for me, including insomnia, joint pain, and irritability. Cannabis is a better option for me since it doesn't have the same side effects.

5

Patient Review

5/29/2015

Asmanex Twisthaler for Asthma

I found that the medication didn't always work by itself, so I started to research other methods. I heard that certain vegetables could help if eaten regularly, so I started drinking smoothies with veggies 2-3 times a week. This method almost completely stopped my attacks.

5

Patient Review

11/13/2018

Asmanex Twisthaler for Controller Medication for Asthma

I refused to take this medication 2 years ago because I don't suffer from asthma and I exercise 4 times a week. But pneumologist insists I could be breathing better based on my test results. After less than 1 week of taking this poison, I started feeling chest tightness, overall weakness, nausea and insomnia. So I took this so-called medecine and threw in the trash. Thanks for everything doc.

5

Patient Review

1/29/2021

Asmanex Twisthaler for Controller Medication for Asthma

I've had asthma since I was a kid, and nothing has ever worked to control it— until now. After a month of taking Asmanex, my asthma is gone. It's worth it to have to take the medication every day in order to get some relief.

4.3

Patient Review

12/6/2014

Asmanex Twisthaler for Severe Chronic Obstructed Lung Disease

The container was completely used, with no product left inside. This is a very poor dispensing method.

4.3

Patient Review

2/27/2022

Asmanex Twisthaler for Asthma

There have been several occasions where the dose marker on my inhaler was off, making it difficult to tell if I was actually receiving any medication. I'm currently looking for a way to document and report this issue.

3.7

Patient Review

10/14/2014

Asmanex Twisthaler for Asthma

I developed a severe itch on my scalp and ears while taking this medication. The itching and rash on my legs and feet worsened even after I stopped taking it. I didn't experience any relief until I took a steroid dose pak.

3.3

Patient Review

4/22/2014

Asmanex Twisthaler for Asthma

I was on this medication for a while and it gave me some serious heartburn. I also started to become really paranoid, which is not like me at all. Additionally, I noticed that my short-term memory was getting worse and worse. Once I stopped taking the asmanex, though, my short-term memory came back within just a couple of weeks.

3.3

Patient Review

2/8/2022

Asmanex Twisthaler for Asthma

I had a lot of trouble breathing at night last year to the point where I would wake up gasping for air. My doctor prescribed an emergency inhaler, but it didn't do anything. eventually, they put me on Twisthaler. It was confusing to use at first, but it worked. However, my nasal passageway still gets restricted from the same allergy that affects my lungs, so I have to use a nasal spray in addition to the Twisthaler or I'll still have trouble breathing at night.

3.3

Patient Review

12/19/2013

Asmanex Twisthaler for Asthma

3.3

Patient Review

11/27/2015

Asmanex Twisthaler for Asthma

I was really struggling with my breathing, trying other inhalers without any success. But as soon as I started using Asmanex, I felt a difference within five days.

3

Patient Review

2/17/2017

Asmanex Twisthaler for Asthma

My son's asthma improved after using this medication for three months; however, he started to experience anxiety and other emotional problems. We had to stop the treatment because of these side effects.

2.7

Patient Review

2/15/2014

Asmanex Twisthaler for Asthma

I found that my lungs functioned better while on the medication, but I also started getting nauseous multiple times a day. I haven't taken it regularly because of this side effect, and whenever I do start taking it again, the nausea returns quickly.

2

Patient Review

10/10/2018

Asmanex Twisthaler for Asthma Prevention

I experienced some weird and vivid dreams while on this medication, as well as joint pain in my hands and lower back pain. I was also irritable.

1.7

Patient Review

10/27/2014

Asmanex Twisthaler for Severe Chronic Obstructed Lung Disease

I'm very suspicious of the doctor who switched me from Advair. I don't feel comfortable taking a medication that has such potential dangers, according to the informational insert.

1.3

Patient Review

7/23/2014

Asmanex Twisthaler for Asthma Prevention

I used asmanex and Spiriva for two months to help with my chronic coughing and wheezing. However, I ended up being hospitalized due to a sinus infection and uncontrolled coughing.

1

Patient Review

10/15/2014

Asmanex Twisthaler for Asthma

Even after getting used to the new inhalation steps, I didn't see as much improvement as I did with other drugs. The price is still outrageous, but it has been effective in reducing the frequency and severity of my asthma attacks.

1

Patient Review

3/7/2020

Asmanex Twisthaler for Asthma

I've been taking this for years and it's the only one that works for me. I tried switching to Singulair a few years ago because of insurance/price, but I got pneumonia within a couple weeks and had to switch back immediately.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about asmanex twisthaler

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Asmanex Twisthaler used for?

"Mometasone is a medication used to control and prevent the symptoms of asthma, such as wheezing and shortness of breath. It must be used regularly to be effective."

Answered by AI

Is Asmanex inhaler a steroid?

"ASMANEX TWISTHALER is a prescription medicine used to prevent and control asthma symptoms. It is taken as a maintenance treatment by people aged 4 and over."

Answered by AI

Is Asmanex Twisthaler being discontinued?

"There is no FDA-approved generic version of Asmanex Twisthaler available in the United States. Be aware that there are many illegal online pharmacies that may try to sell you a generic version of this drug. These medications may be counterfeit and could be unsafe."

Answered by AI

What are the side effects of Asmanex Twisthaler?

"Fungal infections, increased sinus allergy symptoms, sore throats, nosebleeds, headaches, muscle and bone pain, back pain, flu symptoms, indigestion, upset stomachs, menstrual pain, hoarseness, and deepened voices are all possible side effects."

Answered by AI

Clinical Trials for Asmanex Twisthaler

Image of Waianae Coast Comprehensive Health Center in Waianae, United States.

Community Program for Youth Well-Being

12 - 25
All Sexes
Waianae, HI

The goal of this pilot clinical trial is to learn if a community referral program can improve services for youth with mental health and chronic health conditions in a predominantly Native Hawaiian and Pacific Islander community. The main questions the trial aims to address are: * What is the best way for a community health center to connect youth with community programs rooted in cultural practices and traditions? * Does participation in community programs engage youth and mental health and chronic health outcomes? Participants will: * Participate in a community program for youth that will strengthen connection to 'āina (land) and culture. Programs in the summer are 5 hours per day, 4 days a week, for 4 weeks. Programs in the school-year are 2.5 hours per day, 2 days a week, for 16 weeks. * Take surveys on their demographics, general well-being, mental health, and chronic health conditions they may have at 4 different times: Before the program begins, immediately after the program finishes, 3-4 months after finishing, and 6-8 months after finishing. * Have an adult family member complete surveys on their youth's demographics and general well-being at the same 4 times

Recruiting
Has No Placebo

Waianae Coast Comprehensive Health Center

May M Okihrio, MD, MS

Have you considered Asmanex Twisthaler clinical trials?

We made a collection of clinical trials featuring Asmanex Twisthaler, we think they might fit your search criteria.
Go to Trials
Image of San Francisco VA Medical Center in San Francisco, United States.

Dietary Salt for Eczema

18+
All Sexes
San Francisco, CA

The goal of this clinical trial is to evaluate the feasibility of low-sodium diet to improve eczema severity. The main questions it aims to answer are: * Does a low-sodium diet improve eczema severity? * How does a low-sodium diet impact skin sodium concentration? * Is skin sodium concentration associated with eczema severity? Researchers will ask all participant to follow a low-sodium diet, then compare sodium tablets to a placebo (a look-alike substance that contains no drug) to specifically examine the impact of altering sodium intake. Participants will: * Follow a low-salt diet for the duration of the 24-week study * Take sodium chloride tablets every day for 5 weeks followed by a placebo every day for 5 weeks after a 2-week washout period, or vice versa * Complete up to 4 virtual check-in visits * Visit the clinic 4 times to answer questionnaires, provide bio samples, complete dietary recalls, and undergo non-contrast sodium MRI

Phase 4
Waitlist Available

San Francisco VA Medical Center (+1 Sites)

Katrina Abuabara, MD

Image of Corvus Clinical Trials in South San Francisco, United States.

Soquelitinib for Eczema

18+
All Sexes
South San Francisco, CA

The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pill with no medicine in it). To check this, the study doctors will examine participants' skin regularly to track how their AD changes during the study. The study doctors will see how safe soquelitinib is by tracking side effects among participants. They will also check "tolerability," which means how well the participants can handle soquelitinib and whether any potential side effects are manageable for them. To understand how well soquelitinib works, it will be compared with a placebo. Placebo is a substance that looks like soquelitinib but contains no active medicine in it. Participants will: * Take study treatment (soquelitinib or placebo) every day for 12 weeks * Visit the clinic for check-ups and tests every week for the first 2 weeks then every 2 weeks during the treatment period, and then return for follow-up visits 30, 60, and 90 days after the last dose of study treatment

Phase 2
Recruiting

Corvus Clinical Trials

Isin Sinem Bagci, MD

Corvus Pharmaceuticals, Inc.

Have you considered Asmanex Twisthaler clinical trials?

We made a collection of clinical trials featuring Asmanex Twisthaler, we think they might fit your search criteria.
Go to Trials
Image of ALS Global in Irving, United States.

GX-03 for Eczema

18 - 80
All Sexes
Irving, TX

This is a Phase 2, randomized, double-blind, vehicle-controlled clinical study evaluating the efficacy and safety of GX-03 topical ointment in adult subjects with moderate to severe atopic dermatitis (eczema). The study plans to enroll up to 120 eligible patients with a target of at least 100 completing the study and an ability to expand enrollment up to 200 subjects based on a pre-specified interim assessment conducted by an Independent Data Monitoring Committee (IDMC). Subjects will be randomized in a 1:1 ratio to receive either GX-03 or vehicle control for 8 weeks. The study is designed to evaluate improvement in investigator-assessed disease severity, itch, and patient-reported eczema symptoms following topical treatment with GX-03 compared with vehicle control. Efficacy assessments include the Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™), Eczema Area and Severity Index (EASI), Peak Pruritus Numeric Rating Scale (PP-NRS), and Patient-Oriented Eczema Measure (POEM). An interim assessment of conditional power for the primary efficacy endpoint will occur after the first 50 subjects complete the Week 8 visit or withdraw prematurely. Based on pre-specified criteria defined in the IDMC Charter, the IDMC may recommend continuation as planned, expansion of enrollment up to 200 subjects, or early curtailment of enrollment.

Phase 2
Recruiting

ALS Global

Turn Therapeutics

Image of Seeding Labs INC in Austin, United States.

Tailored Recommendations for Infant Gut Microbiome

No minimum age - 3
All Sexes
Austin, TX

The goal of this clinical trial is to learn whether microbiome analysis, education, and personalized recommendations can improve gut health and reduce early markers of immune-related conditions in infants aged 0-3 months delivered via Cesarean section. The study aims to determine whether these interventions can increase beneficial bacteria, decrease C-section-associated microbiome signatures, reduce opportunistic pathogens, and improve functional potential for HMO digestion and SCFA production. The study also seeks to assess whether improvements in microbiome composition are associated with a reduced prevalence of early atopic symptoms. Researchers will compare three groups: a full intervention arm that receives microbiome reports, coaching, personalized recommendations, and educational materials; a limited intervention arm that receives simplified reports and basic recommendations; and a control arm that receives no results until study completion. This design allows evaluation of both a comprehensive intervention and a more scalable, minimal-results model. Participants will: 1. Provide six microbiome stool samples over a 24-month period. 2. Provide additional small stool samples at two timepoints for exploratory metabolomic analysis. 3. Receive microbiome reports and guidance according to their assigned study arm. 4. Complete surveys on infant health history, symptoms, diet, and environmental exposures. 5. Participate in standardized eczema assessment(s) administered by a Nurse Practitioner and evaluated by a Pediatric Allergy Specialist if any symptoms are reported. This study seeks to demonstrate that targeted microbiome support can positively shift gut microbial development in C-section infants and may reduce risks linked to the early stages of the atopic march. Findings may inform scalable strategies for delivering microbiome-based support in early life and improve long-term health outcomes for this high-risk population.

Recruiting
Has No Placebo

Seeding Labs INC

Qian Yuan, MD

Seeding, Inc DBA Tiny Health

Image of Johns Hopkins Bayview Medical Center in Baltimore, United States.

VR-Enhanced PMR for Post-Burn Symptoms

18+
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)

Recruiting
Has No Placebo

Johns Hopkins Bayview Medical Center

Sheera Lerman Zohar, PhD

Verified
Image of Velocity Clinical Research - Medford in Medford, United States.

ENV-294 for Asthma

18 - 75
All Sexes
Medford, OR

This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants will take oral ENV-294 or placebo once daily for 12 weeks. The study includes a screening period of up to 28 days before randomization to confirm eligibility. Study visits and assessments will be conducted to monitor safety, measure drug levels in the blood, and evaluate effects on asthma control and lung function.

Phase 2
Recruiting
Quick Reply

Velocity Clinical Research - Medford (+11 Sites)

Gurpreet Ahluwalia, PhD

Enveda Therapeutics

Have you considered Asmanex Twisthaler clinical trials?

We made a collection of clinical trials featuring Asmanex Twisthaler, we think they might fit your search criteria.
Go to Trials